Close

Mylan (MYL) Plans to Launch Generic EpiPen; Will Cost 50% Less than Name Brand

August 29, 2016 6:06 AM EDT Send to a Friend
Mylan N.V. (Nasdaq: MYL) announced that its U.S. subsidiary will launch the first generic to EpiPen Auto-Injector (epinephrine injection, USP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login